Matinas BioPharma Holdings, Inc. (MTNB) Stock Overview
NYSE American · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules,…
Source: Yahoo Finance
Sector & Industry
Matinas BioPharma Holdings, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NYSE American exchange.
Matinas BioPharma Holdings, Inc. at a Glance
| Company | Matinas BioPharma Holdings, Inc. |
| Ticker | MTNB |
| Exchange | NYSE American |
| Currency | USD |
| Price | $0.18 |
| Market cap | $2.67M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$1.15 |
| 52-week high | $2.14 |
| 52-week low | $0.17 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.70 |
| Return on equity (ROE) | -141.24% |
| Debt-to-equity | 0.33% |
| Average volume | 5.51M |
| Shares outstanding | 14.69M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 2 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Matinas BioPharma Holdings, Inc.'s current P/E ratio?
- Matinas BioPharma Holdings, Inc. (MTNB) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Matinas BioPharma Holdings, Inc.'s market capitalisation?
- Matinas BioPharma Holdings, Inc.'s market cap is $2.67M based on our latest snapshot. See how it ranks by market cap →
- What is MTNB's 52-week range?
- Over the past 52 weeks, MTNB has traded between $0.17 and $2.14. What does the 52-week range mean? →
- How volatile is Matinas BioPharma Holdings, Inc. compared to the market?
- Matinas BioPharma Holdings, Inc. has a beta of 1.70, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Matinas BioPharma Holdings, Inc. pay a dividend?
- Matinas BioPharma Holdings, Inc. does not currently pay a dividend according to our latest data.
- What exchange is MTNB listed on?
- MTNB is listed on the NYSE American. Browse all NYSE American-listed stocks →
- What sector is Matinas BioPharma Holdings, Inc. in?
- Matinas BioPharma Holdings, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →